×
Glaukos Inventory 2014-2024 | GKOS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Glaukos inventory for the quarter ending December 31, 2024 was
$0.060B
, a
50.56% increase
year-over-year.
Glaukos inventory for 2024 was
$0.058B
, a
37.37% increase
from 2023.
Glaukos inventory for 2023 was
$0.042B
, a
10.95% increase
from 2022.
Glaukos inventory for 2022 was
$0.038B
, a
64.45% increase
from 2021.
View More
Glaukos Inventory 2014-2024 | GKOS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Glaukos inventory for 2024 was
$0.058B
, a
37.37% increase
from 2023.
Glaukos inventory for 2023 was
$0.042B
, a
10.95% increase
from 2022.
Glaukos inventory for 2022 was
$0.038B
, a
64.45% increase
from 2021.
Related Stocks
Company Name
Market
Cap
Intuitive Surgical (ISRG)
$216.7B
Thermo Fisher Scientific (TMO)
$203.1B
Alcon (ALC)
$44.2B
Edwards Lifesciences (EW)
$44B
IDEXX Laboratories (IDXX)
$36.9B
DexCom (DXCM)
$35B
IQVIA Holdings (IQV)
$34.6B
Mettler-Toledo (MTD)
$27.3B
Waters (WAT)
$22.4B
STERIS (STE)
$21.8B
SONOVA HOLDING (SONVY)
$19.6B
Hologic (HOLX)
$14.4B
Fresenius Medical Care AG KGaA (FMS)
$13.6B
Penumbra (PEN)
$11.7B
Sysmex ADR (SSMXY)
$11.5B
Globus Medical (GMED)
$11.5B
Masimo (MASI)
$9.6B
Teleflex (TFX)
$8.1B
Integer Holdings (ITGR)
$4.8B
Inari Medical (NARI)
$4.7B
PROCEPT BioRobotics (PRCT)
$3.5B
Veracyte (VCYT)
$3.3B
Nihon Kohden (NHNKY)
$2.7B
TransMedics (TMDX)
$2.7B
LivaNova (LIVN)
$2.6B
Elekta AB (EKTAY)
$2.3B
Tandem Diabetes Care (TNDM)
$2.1B
Integra LifeSciences Holdings (IART)
$1.7B
Alphatec Holdings (ATEC)
$1.5B
Pulse Biosciences (PLSE)
$1.2B